Health status perception and airflow obstruction in five Latin American cities: The PLATINO study

Respiratory Medicine

Volumn 103, Issue 9, 2009, Pages 1376-1382

  Montes de Oca, Maria ^a   Tálamo, Carlos ^a   Halbert, Ronald J ^b   Perez Padilla, Rogelio ^c   Lopez, Maria Victorina ^d   Muiño, Adriana ^d   Jardim, José Roberto B ^e   Valdivia, Gonzalo ^f   Pertuzé, Julio ^f   Moreno, Dolores ^a   Menezes, Ana Maria B ^g  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Institute of Respiratory Diseases   (Mexico)

^d UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Epidemiology; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CITY; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; SELF EVALUATION; SOUTH AND CENTRAL AMERICA;

AIRWAY OBSTRUCTION; DYSPNEA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; SPIROMETRY; URBAN HEALTH;

EID: 68249111364     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.03.005     Document Type: Article

References (30)

1. Menezes A.M., Perez-Padilla R., Jardim J.B., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366 (2005) 1875-1881
2. Halbert R.J., Natoli J.L., Gano A., et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28 (2006) 523-532
3. Zhong N., Wang C., Yao W., et al. Prevalence of chronic obstructive pulmonary disease in China: a large population-based survey. Am J Respir Crit Care Med (2007 Jun 15)
4. Buist A.S., McBurnie M.A., Vollmer W.M., et al., BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370 (2007) 741-750
5. Mannino D.M., and Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 (2007) 502-506
6. Talamo C., Montes de Oca M., Halbert R., et al. Diagnostic labeling of chronic obstructive pulmonary disease in five Latin American cities. Chest 131 (2007) 60-67
7. Pena V.S., Miravitlles M., Gabriel R., et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 118 (2000) 981-989
8. Isoaho R., Puolijoki H., Huhti E., et al. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 88 (1994) 571-580
9. Fukuchi Y., Nishimura M., Ichinose M., et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 9 (2004) 458-465
10. Lundback B., Lindberg A., Lindstrom M., et al. Obstructive lung disease in Northern Sweden studies. Not 15 but 50% of smokers develop COPD? - Report from the obstructive lung disease in northern Sweden studies. Respir Med 97 (2003) 115-122
11. Mannino D.M., Gagnon R.C., Petty T.L., et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 160 (2000) 1683-1689
12. López M.V., Muiño A., Pérez Padilla R., et al. Tratamiento de la enfermedad pulmonar obstructiva crónica en cinco ciudades de América Latina: estudio PLATINO. Arch Bronconeumol 44 (2008) 58-64
13. Kim S., Kim Y., Jung K., et al. Prevalence of chronic obstructive pulmonary disease in Korea. A population-based spirometry survey. Am J Respir Crit Care Med 172 (2005) 842-847
14. Rennard S., Decramer M., Calverley P.M., et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey. Eur Respir J 20 (2002) 799-805
15. Hajiro T., Nishimura K., Tsukino M., et al. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 785-790
16. Tsukino M., Nishimura K., Ikeda A., et al. Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 110 (1996) 896-903
17. Voll-Aanerud M., Eagan T.M., Wentzel-Larsen T., et al. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med 102 (2008) 399-406
18. Menezes A.M., Victora C.G., Perez-Padilla R., and The PLATINO Team. The PLATINO project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 4 (2004) 15
19. Perez-Padilla R., Valdivia G., Muiño A., et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over. Arch Bronconeumol 42 (2006) 317-325
20. Pauwels R.A., Buist A.S., Calverley P.M., et al., GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) work-shop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
21. Gandek B., Ware J.E., Aaronson N.K., et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51 (1998) 1171-1178
22. Bestall J.C., Paul E.A., Garrod R., et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54 (1999) 581-586
23. Coultas D.B., Mapel D., Gagnon R., et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 164 (2001) 372-377
24. Hynninen M.J., Pallesen S., and Nordhus I.H. Factors affecting health status in COPD patients with co-morbid anxiety or depresión. Int J Chron Obstruct Pulmon Dis 2 (2007) 323-328
25. Ng T.P., Niti M., Tan W.C., et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167 (2007) 60-67
26. Mahler D.A., and Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 145 (1992) 467-470
27. Redelmeier D.A., Goldstein R.S., Min S.T., et al. Spirometry and dyspnea in patients with COPD: when small differences mean little. Chest 109 (1996) 1163-1168
28. Guyatt G.H., Townsend M., Keller J., et al. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 85 Suppl. B (1991) 17-21
29. Jones P.W. Health status measurement in chronic obstructive pulmonary disease. Thorax 56 (2001) 880-887
30. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012